富可伊丹和富可伊丹寡糖类的进展:目前的状况,未来的前景和生物应用
Hamed I Hamouda1, Tang Li2, Samah Shabana3
1Dalian Engineering Research Center for Carbohydrate Agricultural Preparations, Dalian Technology Innovation Center for Green Agriculture, Liaoning Provincial Key Laboratory of Carbohydrates, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; Processes Development Department, Egyptian Petroleum Research Institute (EPRI), Nasr City 11727, Cairo, Egypt.
Carbohydrate polymers
|May 18, 2025
概括
富科伊丹是一种来自海藻的硫化多糖,具有强大的抗炎和抗癌特性. 它的复杂结构影响生物活性,高硫化和低分子量增强了各种疾病的治疗潜力.
科学领域:
- 海洋生物技术 海洋生物技术
- 碳水化合物化学 碳水化合物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 来自海藻的硫酸多糖 (SPS) 是具有多种应用的生物活性化合物.
- 富可伊丹 (Fucoidan) 是一种富含L-和硫酸盐群的复杂SPS,在棕色海藻和其他生物体中发现.
- 富科伊丹具有显著的抗炎,抗癌,抗病毒,抗血栓,低脂和免疫调节性质.
研究的目的:
- 提供关于富可伊丹的当前研究状况的全面审查.
- 为了探索福柯丹的来源,提取,净化,结构变异和生物活动.
- 突出富可伊丹及其寡糖化物 (FO) 的潜在健康益处和诊断应用.
主要方法:
- 关于fucoidan的科学出版物的文献综述.
- 对富可伊丹的提取和净化技术的分析.
- 检查富可伊丹的结构-活性关系和生物效应.
主要成果:
- 富科伊丹的生物活性受其物种依赖的结构复杂性,硫化程度和分子量的影响.
- 较高的硫化和较低的分子量通常与增强的生物活性相关.
- 富科伊丹寡糖 (FO) 在代谢过程和疾病诊断中至关重要.
结论:
- 富科伊丹是一种有前途的生物活性化合物,具有多种治疗和诊断潜力.
- 对富可伊丹的结构和生物活性进行进一步的研究可以打开新的健康应用.
- 了解富科伊丹的变异是优化其在医学和生物技术中的使用的关键.
相关概念视频
Oligosaccharide Assembly
2.7K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
FISH - Fluorescent In-situ Hybridization
19.4K
Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...
19.4K


